A Rhenovia Pharma is a R&D pharmaceutical and biotechnology company created in May 2007.
We are headquartered near the Maison du Technopole in Mulhouse.
It has been founded by an international team highly committed to find new solutions to treat Alzheimer's disease (AD) and other diseases of the central nervous system (CNS).
Rhenovia has the legal form of an SAS. At present, it is mainly funded by the founders and the team.
